Generation of human regulatory T cells by bacterial toxins...

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S320100

Reexamination Certificate

active

07494812

ABSTRACT:
An adoptive immunotherapy using ex vivo-generated regulatory T cells may be used for the suppression of undesireable immune response. T cells are to be obtained from the patient's blood, and upon exposure to a set of toxins from the pathogenA. actinomycetemcomitans, the population of regulatory T cells will be enriched ex vivo and adoptively transferred back to the patient. The novel aspect of the present invention is that it generates large numbers of type 1 regulatory T cells, which secrete Interleukin-10.

REFERENCES:
patent: 5847257 (1998-12-01), Seo et al.
patent: 5958416 (1999-09-01), Birnbaum et al.
patent: 5993803 (1999-11-01), Cohen et al.
patent: 6451316 (2002-09-01), Srivastava
patent: 2006/0177461 (2006-08-01), Young et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Generation of human regulatory T cells by bacterial toxins... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Generation of human regulatory T cells by bacterial toxins..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Generation of human regulatory T cells by bacterial toxins... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4057829

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.